Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biotechniques|December 5, 2006
Whole genome amplification of sodium bisulfite-treated DNA allows the accurate estimate of methylated cytosine density in limited DNA resourcesJonathan Mill, Simin Yazdanpanah, Eva Gückel, et al.
Respiratory Research|January 5, 2023
In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbationsHeinrich Worth, Roland Buhl, Carl-Peter Criée, et al.
Plos One|June 1, 2011
Cell-intrinsic NF-κB activation is critical for the development of natural regulatory T cells in miceEva Gückel, Silke Frey, Mario M Zaiss, et al.
Respiratory Research|May 3, 2022
Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' studyClaus F Vogelmeier, Heinrich Worth, Roland Buhl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2010
Siglec-G regulates B1 cell survival and selectionJulia Jellusova, Sandra Düber, Eva Gückel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2010
Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the ratRegina Vogelbacher, Silke Meister, Eva Gückel, et al.
Autoimmunity|October 9, 2009
Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosisVilma Urbonaviciute, Silke Meister, Barbara G Fürnrohr, et al.
European Journal of Immunology|August 8, 2014
Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapyIsabell A Pfeiffer, Stefanie Hoyer, Kerstin F Gerer, et al.
Arthritis and Rheumatism|March 2, 2011
Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritisKarin Polzer, Kirsten Neubert, Silke Meister, et al.
Annals of Hematology|May 12, 2026
Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study)Martin Griesshammer, Eyck von der Heyde, Rudolf Schlag, et al.
Pageof 2